WilliamJFisherMD

PubMed

• The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.
  Agnelli G, George DJ, Fisher W, Kakkar AK, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Turpie AGG> ;J. Clin. Oncol.. 2011-06-20
• The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.
  Agnelli G, George DJ, Fisher W, Kakkar AK, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Turpie AGG> ;J. Clin. Oncol.. 2011-05-20
• Multicenter randomized controlled phase III clinical trial using TNFerade (TNF) with chemoradiation (CRT) in patients with locally advanced pancreatic cancer (LAPC): I...
  Chang KJ, Fisher W, Kenady D, Klapman J, Posner M, Reid T, Rosemurgy A, Shah R, Zervos E, Laheru D> ;J. Clin. Oncol.. 2009-05-20
• Randomized, double blind, multicenter, phase II study of pemetrexed (PEM), carboplatin (CARBO), bevacizumab (BEV) with enzastaurin (ENZ) or placebo (PBO) in chemothera...
  Casey EM, Harb W, Bradford D, Bufill J, Nattam S, Patel J, Fisher W, Latz JE, Wu J, Hanna N> ;J. Clin. Oncol.. 2009-05-20
• Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lu...
  Hanna, N.,Neubauer, M.,Yiannoutsos, C.,McGarry, R.,Arseneau, J.,Ansari, R.,Reynolds, C.,Govindan, R.,Melnyk, A.,Fisher, W.,Richards, D.,Bruetman, D.,Anderson, T.,Chowh...> ;J. Clin. Oncol.. 2008 Nov 13
• Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable...
  Mina LA, Neubauer MA, Ansari RH, Govindan R, Einhorn LH, Fisher W, Bruetman D, Chowhan NM, Johnson C, Hanna NH> ;J. Clin. Oncol.. 2008-05-20
• Pemetrexed in patients (pts) with relapsed small cell lung cancer (SCLC): A phase II study from the Hoosier Oncology Group.
  Hanna NH, Ansari R, Bhatia S, Govindan R, Bruetman D, Hosford M, Fisher W, White A, Breen T, Juliar B> ;J. Clin. Oncol.. 2006-06-20
• Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer (NSCLC): A phase II study from the Hoosier Oncology Group.
  Agarwala AK, Einhorn L, Fisher W, Bruetman D, McClean J, Taber D, Titzer M, Juliar B, Breen T, Hanna N> ;J. Clin. Oncol.. 2006-06-20
• A multicenter randomized phase II study of docetaxel (D) plus vinorelbine (VRB) and docetaxel plus estramustine (EMP) in combination for the treatment of hormone refra...
  Hahn NM, Fisher W, Langdon R, Zon R, Mark B, Sweeney CJ> ;J. Clin. Oncol.. 2005-06-01
• Join now to see all